FutureMeds

FutureMeds, founded in 2019, is a European Site Network and DCT service provider that focuses on patient-centric clinical trials and delivering high-quality data for leading Sponsors & CROs. With 24 strategically located sites, over 220 experienced investigators, and more than 1350 homecare providers, the company offers site and DCT solutions across a wide range of therapeutic areas. FutureMeds prides itself on providing reliability, efficiency, and accuracy to help clients accelerate patient access to new treatments in the pharmaceutical industry. For those seeking to understand how FutureMeds can support their trials, they are encouraged to reach out to the team or visit futuremeds.com. For those interested, the LinkedIn Privacy Policy can be found at here.